July 31, 2025

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring Revenue Growth Amidst Industry Challenges

Aurora Cannabis Inc. (NASDAQ: ACB), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is drawing considerable attention from investors due to its..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Unveiling a 193% Upside Potential Amid Robust Buy Ratings

Abeona Therapeutics Inc. (NASDAQ: ABEO), a promising player in the healthcare sector, has caught the attention of investors with its significant upside potential and a robust pipeline of cutting-edge therapies...

Cidara Therapeutics, Inc. (CDTX) Investor Outlook: Biotechnology Leader with Analyst Confidence and Projected Growth

Cidara Therapeutics, Inc. (CDTX) is a biotechnology company that has piqued investor interest with its innovative approach to developing targeted therapies for severe diseases like cancer and invasive fungal infections...

Anbio Biotechnology (NNNN) Stock Analysis: A Rising Star in Medical Instruments with a 642% Yearly Surge

Anbio Biotechnology (NNNN), a German healthcare company specializing in medical instruments and supplies, has caught the attention of investors with its remarkable stock performance over the past year. Despite a..

ServiceTitan, Inc. (TTAN) Stock Analysis: A Promising 8.48% Upside Amidst Strong Revenue Growth

ServiceTitan, Inc. (TTAN), a leader in the application software industry, has been making waves with its innovative cloud-based solutions aimed at streamlining business operations across a variety of sectors. With..

Pacific Biosciences (PACB) Stock Analysis: Exploring a 37.92% Potential Upside in the Healthcare Sector

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a notable player in the healthcare sector, is gaining attention for its innovative contributions to the medical devices industry. Headquartered in Menlo Park,..

Checkpoint Therapeutics, Inc. (CKPT): Growth Potential in Oncology with a 4.46% Upside

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) stands at a pivotal juncture in the healthcare sector, drawing investor attention as it navigates the complex biotechnology landscape with a focus on immunotherapy and..

Marti Technologies, Inc. (MRT): Investor Outlook Reveals a Potential 112% Upside

Investors looking for high-growth potential in the dynamic world of urban mobility should take a closer look at Marti Technologies, Inc. (MRT). This Turkey-based technology company is making waves with..

Fulcrum Therapeutics, Inc. (FULC) Investor Outlook: Exploring a Potential 60% Upside in Biotech Innovation

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is making waves in the biotechnology sector with its focus on developing small molecules to address genetically defined diseases. With a current market capitalization of..

Grab Holdings Limited (GRAB): Investor Outlook and Growth Potential with a 11.74% Upside

Grab Holdings Limited (NASDAQ: GRAB) is an intriguing player in the technology sector, particularly within the Software – Application industry. As a pioneering force in Southeast Asia, Grab has carved..

Mereo BioPharma Group plc (MREO): Analyst Consensus Points to Remarkable 310% Upside Potential

Mereo BioPharma Group plc (NASDAQ: MREO), a dynamic player in the biotechnology sector, is capturing investor attention with its compelling growth narrative and significant upside potential. With a market capitalization..

Alumis Inc. (ALMS) Stock Analysis: Unveiling a 398% Potential Upside in Biotech

In the ever-evolving landscape of biotechnology, Alumis Inc. (NASDAQ: ALMS) stands out as a promising contender with a striking potential upside of 398.26%. This clinical-stage biopharmaceutical company, headquartered in South..

Quantum-Si Incorporated (QSI) Investor Outlook: Analyzing a 74.90% Potential Upside in the Healthcare Sector

Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector with its cutting-edge advancements in Next Generation Protein Sequencing (NGPS). As a key player in the medical devices industry,..

TotalEnergies SE (TTE) Stock Analysis: Exploring a 15% Upside Potential

TotalEnergies SE (TTE), a major player in the global energy sector, continues to capture the attention of investors with its diverse portfolio and strategic positioning in the oil and gas..

Canopy Growth Corporation (CGC) Stock Analysis: Is a 259% Upside Within Reach?

Investors with an eye on the healthcare sector, particularly the burgeoning cannabis industry, may find Canopy Growth Corporation (NASDAQ: CGC) a company worth watching. Despite facing significant challenges, recent analyst..

Varex Imaging Corporation (VREX) Investor Outlook: Unpacking a 122.82% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX), a pivotal player in the healthcare sector, primarily focuses on the development and sale of X-ray imaging components. With a market capitalization of $309.27 million,..

Health Catalyst, Inc (HCAT) Stock Analysis: Exploring an 87.20% Potential Upside for Investors

Health Catalyst, Inc (NASDAQ: HCAT), a key player in the health information services sector, provides innovative data and analytics technology solutions for healthcare organizations across the United States. With a..

Fair Isaac Corporation (FICO) Stock Analysis: Exploring 35% Potential Upside for Tech-Savvy Investors

Fair Isaac Corporation, trading under the ticker FICO, stands as a formidable player in the technology sector, particularly within the software application industry. With a market capitalization of $37.19 billion,..

Phathom Pharmaceuticals (PHAT) Investor Outlook: Analyzing a Potential 128% Upside in Biotech

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) presents an intriguing opportunity for investors within the dynamic biotechnology sector. With a market capitalization of $608.08 million and a compelling upside potential of 128.19%,..

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a Potential 226% Upside in the Biotech Sector

Aura Biosciences, Inc. (NASDAQ: AURA) is capturing the attention of investors with its promising potential in the biotechnology sector. As a clinical-stage biotech company, Aura is pioneering precision therapies aimed..

Search

Funds

July 31, 2025

Search

Funds

July 31, 2025

FTSE 100

Funds